Nitric oxide production in arterial vessels of cirrhotic rats

Hepatology

Volumn 21, Issue 2, 1995, Pages 554-560

  Ros, Josefa ^a   Jimenez, Wladimiro ^a   Lamas, Santiago ^b   Claria, Joan ^a   Arroyo, Vicente ^a   Rivera, Francisca ^a   Rodes, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CYCLIC GMP; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; ASCITES; CONTROLLED STUDY; LIVER CIRRHOSIS; LIVER TOXICITY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA;

ANIMAL; ARTERIES; BIOCHEMISTRY; BRADYKININ; CYCLIC GMP; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T;

EID: 0028905429     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90119-1     Document Type: Article

References (45)

1. Hepatic hemodynamics and the renin-angiotensinaldosterone system in cirrhosis
2. Circulation times in the splanchnic and hepatic beds in alcoholic liver disease
3. Increased blood flow through portal system in cirrhotic rats
4. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis
5. Ascites, renal failure, and electrolyte disorders in cirrhosisa
6. Splanchnic hemodynamics in chronic portal venous hypertension
7. Prostaglandins: modulators of renal function and pressor reactivity in chronic liver disease
8. Circulating endogenous vasoactive intestinal polypeptide (VIP) in patients with uraemia and liver cirrhosis
9. Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis
10. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
11. Nitric Oxide as a secretory product of mammalian cells
12. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide (NO)
13. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide
14. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats
15. Carbon tetrachloride induced cirrhosis in rats a useful tool for investigating the pathogenesis of ascites in chronic liver disease
16. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat fetal lung fibroblasts by activating different forms of guanylate cyclase
17. A simple and sensitive bioassay method for detection of EDRF with RFL-6 lung fibroblasts
18. Atrial natriuretic factors stimulate accumulation and efflux of cyclic GMP in C6-2B rat glioma and PC12 rat pheochromocytoma cell cultures
19. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase
20. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform
21. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
22. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells
23. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway
24. Protective and pathological roles of nitric oxide in endotoxin shock
25. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension
26. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats
27. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats
28. Inhibition of nitric oxide synthesis in the human forearm arterial bed of patients with liver cirrhosis
29. Nitric oxide and the hemodynamic changes in hepatic failure
30. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia
31. Nitric oxide production in patients with chronic liver disease
32. Glomerular endothelial cells respond to calcium mobilizing agonists with release of EDRF
33. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
34. Hormone induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in NIE-115 neuroblastoma cells requires calcium and calmodulin
35. 2/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180
36. Molecular cloning and expression of a cDNA encoding endothelial nitric oxide synthase
37. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase
38. Cloning and expression of a cDNA encoding human endothelium derived relaxing factor/nitric oxide synthase
39. Molecular cloning and characterization of human endothelial nitric oxide synthase
40. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-α
41. Glucocorticoids inhibits the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
42. Vascular hyporesponsiveness to endothelin-1 in rats with cirrhosis
43. Nitric-oxide induced microvascular permeability alterations: a regulatory role for cGMP
44. Nitric oxide: physiology, pathophysiology, and pharmacology